Since inhibiting the expression of anti-apoptotic proteins such as BCL-2, BCL-xL, and BCL-w displays a positive effect on tumor cell apoptosis, a series of anti-cancer reagents targeting BCL-2 have been developed in recent years (Delbridge et al., 2016). Here, BCL2 is linked to cancer.